These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10450971)

  • 1. The spiroketals containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity.
    Mitsuhashi S; Shima H; Kawamura T; Kikuchi K; Oikawa M; Ichihara A; Oikawa H
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2007-12. PubMed ID: 10450971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structure.
    Colby DA; Liu W; Sheppeck JE; Huang HB; Nairn AC; Chamberlin AR
    Bioorg Med Chem Lett; 2003 May; 13(9):1601-5. PubMed ID: 12699764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis.
    Kawamura T; Matsuzawa S; Mizuno Y; Kikuchi K; Oikawa H; Oikawa M; Ubukata M; Ichihara A
    Biochem Pharmacol; 1998 Apr; 55(7):995-1003. PubMed ID: 9605423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways.
    Chatfield K; Eastman A
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein phosphatases-1 and -2A with acanthifolicin. Comparison with diarrhetic shellfish toxins and identification of a region on okadaic acid important for phosphatase inhibition.
    Holmes CF; Luu HA; Carrier F; Schmitz FJ
    FEBS Lett; 1990 Sep; 270(1-2):216-8. PubMed ID: 2171991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity.
    Ju J; Li W; Yuan Q; Peters NR; Hoffmann FM; Rajski SR; Osada H; Shen B
    Org Lett; 2009 Apr; 11(7):1639-42. PubMed ID: 19281218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peniciketals A-C, new spiroketals from saline soil derived Penicillium raistrichii.
    Liu WZ; Ma LY; Liu DS; Huang YL; Wang CH; Shi SS; Pan XH; Song XD; Zhu RX
    Org Lett; 2014 Jan; 16(1):90-3. PubMed ID: 24283621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective inhibition of phosphatases by natural toxins: the anhydride domain of tautomycin is not a primary factor in controlling PP1/PP2A selectivity.
    Liu W; Sheppeck JE; Colby DA; Huang HB; Nairn AC; Chamberlin AR
    Bioorg Med Chem Lett; 2003 May; 13(9):1597-600. PubMed ID: 12699763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
    Ubukata M; Koshino H; Yamasaki C; Fujita K; Isono K
    J Antibiot (Tokyo); 1997 Oct; 50(10):801-7. PubMed ID: 9402983
    [No Abstract]   [Full Text] [Related]  

  • 10. [Total synthesis and conformational analysis of inhibitors].
    Tsuboi K; Isobe M
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1083-90. PubMed ID: 9655966
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
    Fujiki H; Suganuma M
    Adv Cancer Res; 1993; 61():143-94. PubMed ID: 8394044
    [No Abstract]   [Full Text] [Related]  

  • 12. Limaol: A Polyketide from the Benthic Marine Dinoflagellate Prorocentrum lima.
    Yang AR; Lee S; Yoo YD; Kim HS; Jeong EJ; Rho JR
    J Nat Prod; 2017 May; 80(5):1688-1692. PubMed ID: 28383915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apoptosis-inducing activity of the two protein phosphatase inhibitors, tautomycin and thyrsiferyl 23-acetate, is not due to the inhibition of protein phosphatases PP1 and PP2A (review).
    Kikuchi K; Shima H; Mitsuhashi S; Suzuki M; Oikawa H
    Int J Mol Med; 1999 Oct; 4(4):395-401. PubMed ID: 10493981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new pathway of tumor promotion by the okadaic acid class compounds.
    Fujiki H; Suganuma M; Nishiwaki S; Yoshizawa S; Winyar B; Sugimura T; Schmitz FJ
    Adv Second Messenger Phosphoprotein Res; 1990; 24():340-4. PubMed ID: 2169814
    [No Abstract]   [Full Text] [Related]  

  • 15. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
    McCluskey A; Sim AT; Sakoff JA
    J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes.
    Motoyoshi H; Horigome M; Ishigami K; Yoshida T; Horinouchi S; Yoshida M; Watanabe H; Kitahara T
    Biosci Biotechnol Biochem; 2004 Oct; 68(10):2178-82. PubMed ID: 15502365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and biological studies of reveromycin A.
    Osada H
    J Antibiot (Tokyo); 2016 Oct; 69(10):723-730. PubMed ID: 27270304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity.
    Oberdorf C; Schepmann D; Vela JM; Buschmann H; Holenz J; Wünsch B
    J Med Chem; 2012 Jun; 55(11):5350-60. PubMed ID: 22515405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of reveromycin A and its biological activities.
    Shimizu T; Usui T; Machida K; Furuya K; Osada H; Nakata T
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3363-6. PubMed ID: 12419362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent approach to complex spirocyclic pyrans: practical synthesis of the oxa-pinnaic acid core.
    Ferrari FD; Pasqua AE; Ledgard AJ; Marquez R
    Org Biomol Chem; 2013 Jun; 11(21):3469-76. PubMed ID: 23589153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.